BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2506626)

  • 21. [The cost of measles in Spain].
    Taracena del Piñal B; Montón JL; Cristóbal P; González F; Casas J
    An Esp Pediatr; 1983 Nov; 19(5):383-8. PubMed ID: 6660655
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Progress toward measles elimination in Romania after a mass vaccination campaign and implementation of enhanced measles surveillance.
    Pistol A; Hennessey K; Pitigoi D; Ion-Nedelcu N; Lupulescu E; Walls L; Bellini W; Strebel P
    J Infect Dis; 2003 May; 187 Suppl 1():S217-22. PubMed ID: 12721916
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Measles eradication in the Americas: experience in Haiti.
    Venczel L; Dobbins J; André J; Laender F; Izurieta H; Delorme P; Voltaire HC
    J Infect Dis; 2003 May; 187 Suppl 1():S127-32. PubMed ID: 12721903
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Using cost-effectiveness analysis to support research and development portfolio prioritization for product innovations in measles vaccination.
    Garrison LP; Bauch CT; Bresnahan BW; Hazlet TK; Kadiyala S; Veenstra DL
    J Infect Dis; 2011 Jul; 204 Suppl 1():S124-32. PubMed ID: 21666153
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of Lot Quality Assurance Sampling (LQAS) to estimate vaccination coverage helps guide future vaccination efforts.
    Alberti KP; Guthmann JP; Fermon F; Nargaye KD; Grais RF
    Trans R Soc Trop Med Hyg; 2008 Mar; 102(3):251-4. PubMed ID: 18178230
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Specific prevention of measles in Rumania. V. Studies on an attenuated live measles virus vaccine prepared at the Stefan S. Nicolau Institute of Virology and administered in various ways].
    Cajal N; Cepleanu M; Cernesc C; Sorodoc Y; Tigăeru N; Biberi-Moroianu S; Cuciu D; Brebenel G; Vucu E; Petrescu A
    Stud Cercet Virusol; 1973; 24(5):349-56. PubMed ID: 4747453
    [No Abstract]   [Full Text] [Related]  

  • 27. Measles outbreak in 31 schools: risk factors for vaccine failure and evaluation of a selective revaccination strategy.
    Yuan L
    CMAJ; 1994 Apr; 150(7):1093-8. PubMed ID: 8137189
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Epidemiology and prevention of measles in the United States: 30 years of vaccination].
    Chauvin P
    Rev Epidemiol Sante Publique; 1995; 43(1):61-71. PubMed ID: 7892518
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect of previous vaccination on the dynamics of measles outbreak].
    Luna Sánchez A
    Rev Esp Salud Publica; 1997; 71(3):243-7. PubMed ID: 9445752
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Late vaccination reinforcement during a measles epidemic in Niamey, Niger (2003-2004).
    Dubray C; Gervelmeyer A; Djibo A; Jeanne I; Fermon F; Soulier MH; Grais RF; Guerin PJ
    Vaccine; 2006 May; 24(18):3984-9. PubMed ID: 16540214
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The specific prevention of measles in Romania. Study of a vaccine prepared in human diploid cells.
    Cepleanu M; Cajal N; Cernescu C; Sorodoc Y; Aderca I; Tigăeru N; Suciu D; Manu S; Ferra A; Biberimoroianu S; Dobrescu A; Lucian M
    Rev Roum Virol (1972); 1973; 10(1):8-17. PubMed ID: 4709858
    [No Abstract]   [Full Text] [Related]  

  • 32. Measles: effect of a two-dose vaccination programme in Catalonia, Spain.
    Godoy P; Domínguez A; Salleras L
    Bull World Health Organ; 1999; 77(2):132-7. PubMed ID: 10083711
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of measles antibodies before and after vaccination in previously unvaccinated children of the Cordillera Province (Santa Cruz Department, Bolivia).
    Guglielmetti P; Bianchi Bandinelli ML; Bartoloni A; Gamboa H; Roselli M; Valensin PE
    J Trop Med Hyg; 1994 Aug; 97(4):231-5. PubMed ID: 8064946
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Cost-effectiveness analysis on two different measles immunization strategies].
    Wu H; Wang K; Zhang X; Jin S; Feng Z
    Zhonghua Liu Xing Bing Xue Za Zhi; 2000 Apr; 21(2):121-3. PubMed ID: 11860771
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Study of a measles epidemic in Gátova (Castellón) and the efficacy of measles vaccination].
    Colomer Pache M; Arnedo Pena A
    Med Clin (Barc); 1988 Nov; 91(17):649-52. PubMed ID: 3230970
    [No Abstract]   [Full Text] [Related]  

  • 36. Vaccination levels associated with lack of measles transmission among preschool-aged populations in the United States, 1989-1991.
    Hutchins SS; Baughman AL; Orr M; Haley C; Hadler S
    J Infect Dis; 2004 May; 189 Suppl 1():S108-15. PubMed ID: 15106099
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Measles epidemic attributed to inadequate vaccination coverage--Campania, Italy, 2002.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2003 Oct; 52(43):1044-7. PubMed ID: 14586297
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outbreak of measles in a highly vaccinated secondary school population.
    Sutcliffe PA; Rea E
    CMAJ; 1996 Nov; 155(10):1407-13. PubMed ID: 8943928
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mass measles vaccination in urban Burkina Faso, 1998.
    Zuber PL; Conombo KS; Traoré AD; Millogo JD; Ouattara A; Ouédraogo IB; Valian A
    Bull World Health Organ; 2001; 79(4):296-300. PubMed ID: 11357207
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The role of vaccinated individuals in measles morbidity during the vaccination period].
    Deshevoĭ SE; Makarova NT; Petrova VN; Malykhina RM
    Tr Inst Im Pastera; 1983; 61():158-64. PubMed ID: 6235629
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.